Guolian Ren

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Photodynamic Therapy

Reactive Oxygen Species

Top Venues

International journal of nanomedicine

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Bin Zheng, Fei Pan, Minfei Shi, Cuiping He, Beibei He, Rongrong Wang, Guolian Ren, Shuang Yang, Shuqiu Zhang
2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin. International journal of nanomedicine 19 (2024)
Bin Zheng, Fei Pan, Minfei Shi, Cuiping He, Beibei He, Rongrong Wang, Guolian Ren, Shuang Yang, Shuqiu Zhang
2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin. International journal of nanomedicine 19 (2024)
Guolian Ren, Yujie Li, Canqi Ping, Danyu Duan, Ning Li, Jiaqi Tang, Rongrong Wang, Wenju Guo, Xiaomin Niu, Qiuyue Ji, Guoshun Zhang, Ruili Wang, Shuqiu Zhang
Docetaxel prodrug and hematoporphyrin co-assembled nanoparticles for anti-tumor combination of chemotherapy and photodynamic therapy. Drug delivery 29 (1) (2022)
Zhuoya Wan, Runzi Sun, Yang-Wuyue Liu, Sihan Li, Jingjing Sun, Jiang Li, Junjie Zhu, Pearl Moharil, Bei Zhang, Pengfei Ren, Guolian Ren, Min Zhang, Xiaochao Ma, Shuangshuang Dai, Da Yang, Binfeng Lu, Song Li
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science advances 7 (50) (2021)
Guolian Ren, Pei Chen, Jiaqi Tang, Wenju Guo, Rongrong Wang, Ning Li, Yujie Li, Guoshun Zhang, Ruili Wang, Shuqiu Zhang
In vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics. RSC advances 10 (29) (2020)